Future prospects of EGFR-TKIs and surgery for non-small-cell lung cancer

被引：0
|
作者：
Nagano, Tatsuya [1 ]
Tachihara, Motoko [1 ]
Tanaka, Yugo [2 ]
机构：
[1] Kobe Univ, Dept Internal Med, Div Resp Med, Grad Sch Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Div Thorac Surg, Grad Sch Med, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC DISEASE | 2022年 / 14卷 / 04期
关键词：
OSIMERTINIB;
D O I：
10.21037/jtd-22-57
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：809 / 811
页数：3
相关论文
共 50 条
  • [21] ANALYSIS OF THE EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER PATIENTS AFTER EGFR-TKIS TREATMENT
    Matsuo, Midori
    Nanae, Tomonaga
    Koichi, Izumikawa
    Hiroyuki, Yamaguchi
    Takaya, Ikeda
    Katsumi, Nakatomi
    Yoichi, Nakamura
    Kazuhiro, Tsukamoto
    Shigeru, Kohno
    RESPIROLOGY, 2010, 15 : 68 - 68
  • [22] Identification of genetic alterations associated with primary resistance to EGFR-TKIs in advanced non-small-cell lung cancer patients with EGFR sensitive mutations
    Wang, Fang
    Diao, Xia-Yao
    Zhang, Xiao
    Shao, Qiong
    Feng, Yan-Fen
    An, Xin
    Wang, Hai-Yun
    CANCER COMMUNICATIONS, 2019, 39
  • [23] Chemotherapy plus EGFR-TKIs versus EGFR-TKIs Alone in Non-small Cell Lung Cancer with EGFR-Activating Mutations: A Meta-analysis
    Han, G.
    Peng, M.
    Weng, Y.
    Zou, J.
    Song, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E458 - E458
  • [24] Neoadjuvant EGFR TKIs: toward personalized management in non-small-cell lung cancer
    Passaro, Antonio
    Cortesi, Enrico
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (04) : 280 - 282
  • [25] THE RESISTANCE TO EGFR-TKIS IN LUNG CANCER
    Yamada, T.
    Yano, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 77 - 77
  • [26] COMPARISON OF EGFR-TKIS AND PEMETREXED FOR KOREAN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lee, J. H.
    Ryu, Y. J.
    Chun, E. M.
    Chang, J. H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S90 - S90
  • [27] The Association between SNP of EGFR and Response to EGFR-TKIs According to EGFR Mutation in Non-Small Cell Lung Cancer
    Jeon, Eun Kyoung
    Shin, Jung-Young
    Cho, Eun Kyung
    Kang, Jin-Hyoung
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S376 - S376
  • [28] Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance
    Wang, Ying
    Liu, Qiuyun
    Chen, Haojie
    You, Jun
    Peng, Bin
    Cao, Fanfan
    Zhang, Xue
    Chen, Qing
    Uzan, Georges
    Xu, Limin
    Zhang, Denghai
    ANTI-CANCER DRUGS, 2018, 29 (08) : 748 - 755
  • [29] CLINICAL FEATURES OF EARLY INTERRUPTION OF EGFR-TKIS IN UNSELECTED NON SMALL CELL LUNG CANCER PATIENTS
    Jang, Taewon
    Yang, Jungwook
    Oak, Chulho
    Jung, Mannhong
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S573 - S573
  • [30] Cost-effectiveness analysis of the first-line EGFR-TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer
    Aguilar-Serra, J.
    Gimeno-Ballester, V
    Pastor-Clerigues, A.
    Milara, J.
    Trigo-Vicente, C.
    Cortijo, J.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2022, 22 (04) : 637 - 646
12345